These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

332 related articles for article (PubMed ID: 12496702)

  • 1. Evaluation of the relationship between adenosarcoma and carcinosarcoma and a hypothesis of the histogenesis of uterine sarcomas.
    Seidman JD; Chauhan S
    Int J Gynecol Pathol; 2003 Jan; 22(1):75-82. PubMed ID: 12496702
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mixed Endometrioid Adenocarcinoma and Müllerian Adenosarcoma of the Uterus and Ovary: Clinicopathologic Characterization With Emphasis on its Distinction From Carcinosarcoma.
    El Hallani S; Arora R; Lin DI; Måsbäc A; Mateoiu C; McCluggage WG; Nucci MR; Otis CN; Parkash V; Parra-Herran C; Longacre TA
    Am J Surg Pathol; 2021 Mar; 45(3):374-383. PubMed ID: 33565764
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathology of mixed Müllerian tumours.
    D'Angelo E; Prat J
    Best Pract Res Clin Obstet Gynaecol; 2011 Dec; 25(6):705-18. PubMed ID: 21742560
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Uterine sarcomas.
    Mbatani N; Olawaiye AB; Prat J
    Int J Gynaecol Obstet; 2018 Oct; 143 Suppl 2():51-58. PubMed ID: 30306577
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cyclooxygenase-2 expression in malignant mesenchymal tumors and related uterine lesions.
    Matsumoto Y; Ishiko O; Sumi T; Yoshida H; Deguchi M; Nakagawa E; Haba T; Wakasa K; Ogita S; Ando Y
    Oncol Rep; 2001; 8(6):1225-7. PubMed ID: 11605037
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Uterine sarcomas: a review.
    D'Angelo E; Prat J
    Gynecol Oncol; 2010 Jan; 116(1):131-9. PubMed ID: 19853898
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Sarcomas and mixed mesodermal tumors of the uterus].
    Günthert AR
    Ther Umsch; 2011 Oct; 68(10):559-64. PubMed ID: 21968895
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Uterine carcinosarcomas (malignant mixed Mullerian tumors) are metaplastic carcinomas.
    McCluggage WG
    Int J Gynecol Cancer; 2002; 12(6):687-90. PubMed ID: 12445244
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cluster of uterine mullerian adenosarcoma in the Washington, DC metropolitan area with high incidence of sarcomatous overgrowth.
    Seidman JD; Wasserman CS; Aye LM; MacKoul PJ; O'Leary TJ
    Am J Surg Pathol; 1999 Jul; 23(7):809-14. PubMed ID: 10403304
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD34 immunohistochemistry in female genital tract carcinosarcoma (malignant mixed müllerian tumors) supports a dominant role of the carcinomatous component.
    Costa MJ; Guinee D
    Appl Immunohistochem Mol Morphol; 2000 Dec; 8(4):293-9. PubMed ID: 11127921
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Uterine adenosarcoma with sarcomatous overgrowth versus uterine carcinosarcoma: comparison of treatment and survival.
    Krivak TC; Seidman JD; McBroom JW; MacKoul PJ; Aye LM; Rose GS
    Gynecol Oncol; 2001 Oct; 83(1):89-94. PubMed ID: 11585418
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Uterine Carcinosarcomas - Diagnosis and Management.
    Denschlag D; Ulrich UA
    Oncol Res Treat; 2018; 41(11):675-679. PubMed ID: 30317231
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Müllerian adenosarcoma of the uterus: report of a case with imprint cytology.
    Takeshima N; Tabata T; Nishida H; Arai Y; Tsuzuku M; Hirai Y; Yamauchi K; Hasumi K
    Acta Cytol; 2001; 45(4):613-6. PubMed ID: 11480728
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunohistochemical survey of mismatch repair protein expression in uterine sarcomas and carcinosarcomas.
    Hoang LN; Ali RH; Lau S; Gilks CB; Lee CH
    Int J Gynecol Pathol; 2014 Sep; 33(5):483-91. PubMed ID: 25083964
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gynecologic Cancer InterGroup (GCIG) consensus review for mullerian adenosarcoma of the female genital tract.
    Friedlander ML; Covens A; Glasspool RM; Hilpert F; Kristensen G; Kwon S; Selle F; Small W; Witteveen E; Russell P
    Int J Gynecol Cancer; 2014 Nov; 24(9 Suppl 3):S78-82. PubMed ID: 25341585
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mullerian adenosarcoma of the female genital tract.
    McCluggage WG
    Adv Anat Pathol; 2010 Mar; 17(2):122-9. PubMed ID: 20179434
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mullerian adenosarcomas: an immunophenotypic analysis of 35 cases.
    Soslow RA; Ali A; Oliva E
    Am J Surg Pathol; 2008 Jul; 32(7):1013-21. PubMed ID: 18469708
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Staging of uterine sarcomas.
    Tse KY; Crawford R; Ngan HY
    Best Pract Res Clin Obstet Gynaecol; 2011 Dec; 25(6):733-49. PubMed ID: 21752716
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pathologic and molecular features of uterine carcinosarcomas.
    Lopez-Garcia MA; Palacios J
    Semin Diagn Pathol; 2010 Nov; 27(4):274-86. PubMed ID: 21309261
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Post-radiation Mullerian adenosarcoma with sarcomatous overgrowth: rare presentation of an uncommon malignancy.
    Mubeen A; Shahid M; Makary R
    Pathologica; 2020 Dec; 112(4):219-223. PubMed ID: 33393526
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.